An Illinois federal Judge on Friday wiped out a jury's decision to award a man $150 million in punitive damages over his allegation that AbbVie Inc. fraudulently misrepresented what its testosterone replacement drug AndroGel could treat, overturning the result of the first bellwether trial in multidistrict litigation.